![Ingmar Hoerr](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profiel
Ingmar Hoerr was the founder of CureVac NV, where he served as the Chief Executive Officer & Member-Supervisory Board from 2000 to 2020.
Dr. Hoerr is also the founder of CureVac SE.
Dr. Hoerr obtained a doctorate degree from Eberhard Karls Universität Tübingen and an MBA from Donau-Universität Krems.
Actieve functies van Ingmar Hoerr
| Bedrijven | Functie | Begin |
|---|---|---|
CureVac SE
 CureVac SE BiotechnologyHealth Technology Develops tumor immunotherapies | Oprichter | 11-05-2010 |
Eerdere bekende functies van Ingmar Hoerr
| Bedrijven | Functie | Einde |
|---|---|---|
| CUREVAC | Oprichter | 01-03-2020 |
Opleiding van Ingmar Hoerr
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
17
Eerstegraads connecties
4
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
CureVac SE
CureVac SE BiotechnologyHealth Technology Develops tumor immunotherapies | Health Technology |
Eberhard Karls Universität Tübingen
 Eberhard Karls Universität Tübingen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Donau-Universität Krems
 Donau-Universität Krems Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CureVac NV
 CureVac NV BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops medicines based on messenger ribonucleic acid which includes prophylactic vaccines, oncology, and molecular therapies | Health Technology |
